Search for: "Johnson v. Abbott Laboratories Inc"
Results 41 - 60
of 68
Sorted by Relevance
|
Sort by Date
5 Jul 2009, 2:23 pm
After a reported five hours of deliberation, the jury in Centocor Inc v Abbott Laboratories awarded the Johnson & Johnson unit $1.67 billion for Abbott's willful infringement. [read post]
15 Jan 2008, 3:06 am
filed 03/22/07 1:07-cv-01721 Abbott Laboratories et al v. [read post]
13 May 2010, 12:27 pm
Abbott Laboratories, 2009 WL 2231701 (S.D.N.Y. [read post]
3 Feb 2011, 2:11 pm
Hill Laboratories, Inc., 2007 WL 2484889, at *3 (D. [read post]
23 Oct 2008, 10:31 am
" Specifically, "infections triggered safety alerts for the arthritis medicines Enbrel (etanercept), sold by Amgen Inc.; Johnson & Johnson's Remicade (infliximab); and Abbott Laboratories' Humira (adalimumab). [read post]
21 Dec 2012, 11:41 am
Johnson & Johnson, 48 A.3d 1041 (N.J. 2012). [read post]
24 Jun 2010, 5:00 am
Abbott Laboratories, 100 F.R.D. 336 (D. [read post]
31 Dec 2015, 5:12 am
We bid SBA adieu here.Amarin Pharma, Inc. v. [read post]
2 Sep 2010, 8:35 am
RE 39,947 owned by Johnson Research & Development Co., Inc. and entitled TOY WATER GUN. [read post]
9 Aug 2012, 5:00 am
Sanchez & Abbott Labs. [read post]
2 Mar 2012, 6:52 am
ADAC Laboratories (?) [read post]
28 Oct 2011, 7:00 am
Johnson & Johnson, 2011 WL 2003407, at *5 (E.D. [read post]
25 Jun 2008, 6:52 pm
Abbott Laboratories v. [read post]
15 Apr 2009, 4:44 am
Friends for All Children, Inc. v. [read post]
18 Apr 2008, 2:00 am
Lélos Kai Sia EE (and Others) v GlaxoSmithKline AEVE: (IPKat), US: Bio commends Sen Specter for patent reform stance: (Patent Docs), US: USPTO rules on two of four neural stem cell patents in dispute between StemCells Inc and Neuralstem Inc; parties disagree on how extensively claims amended: (IP Law360), (IPBiz), US: Insmed continues fight for generic biologic approval: (GenericsWeb), Pharma & Biotech - Products Cipralex (Escitalopram)… [read post]
9 Dec 2008, 7:03 am
The company has a wide variety of clients, including IBM, Genereal Electric, Motorola, Abbott Laboratories, and Eastman Koday. [read post]
4 Apr 2008, 1:00 am
- Counterfeit cash flooding the market: (Afro-IP), Debranded fakes for Liberia: an update: (Afro-IP), South African music industry blames pirates for falling sales of local artists: (Afro-IP), Plaintiff obtains interlocutory relief in patent case Sanitam Services Limited v Bins (Nairobi) Services Limited: (Afro-IP), South Africa – new patent judgments: Buckman Laboratories v Bromine Compounds; Northpark Trading 3 (Pty) Ltd v Ausplow (Pty)… [read post]
25 Jan 2008, 1:00 am
: (Generic Pharmaceuticals & IP),Arava (Leflunomide) - Sanofi-Aventis loses bid to dismiss Louisiana Wholsesale Drug Co's antitrust claims accusing S-A of unlawfully blocking generic competition for Arava by filing a sham Citizen Petition with the USFDA: (IP Law360),Ciprofloxacin - CIPLA issued notice by National Pharmaceutical Pricing Authority for allegedly overpricing its antibiotic Ciprofloxacin (especially of note because CIPLA is objecting… [read post]
17 Mar 2020, 1:32 pm
NEUTROGENA® and AVEENO® Aerosol Sunscreen Products have been recalled by Johnson & Johnson Consumer Inc. due to the presence of benzene. [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
